Patent 7659412 was granted and assigned to Bayer Healthcare on February, 2010 by the United States Patent and Trademark Office.
The invention relates to novel benzofuran derivatives, processes for their preparation and their use for preparing medicaments for the treatment or prophylaxis of disorders, especially of hyperproliferative disorders.